Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-13 Sale |
2024-06-17 7:19 pm |
uniQure N.V. | QURE | Gut Robert Director |
3,504 | $5.12 | $17,940 | 44,165 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-20 5:20 pm |
uniQure N.V. | QURE | Gut Robert Director |
3,228 | $18.88 | $60,945 | 64,729 (Direct) |
View |
| 2023-02-27 Sale |
2023-03-01 4:09 pm |
uniQure N.V. | QURE | Gut Robert Director |
1,968 | $20.79 | $40,907 | 42,197 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 4:41 pm |
uniQure N.V. | QURE | Gut Robert Director |
1,602 | $16.7 | $26,753 | 35,085 (Direct) |
View |
| 2022-01-26 Sale |
2022-01-28 5:08 pm |
uniQure N.V. | QURE | Gut Robert Director |
2,348 | $18.12 | $42,546 | 35,153 (Direct) |
View |
| 2021-09-21 Sale |
2021-09-22 09:32 am |
uniQure N.V. | QURE | Gut Robert Director |
4,500 | $36.61 | $164,745 | 37,501 (Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 2:23 pm |
uniQure N.V. | QURE | Gut Robert Director |
1,300 | $36.98 | $48,074 | 42,001 (Direct) |
View |
| 2021-01-26 Sale |
2021-01-28 10:49 am |
uniQure N.V. | QURE | Gut Robert Chief Medical Officer |
604 | $39.09 | $23,610 | 40,919 (Direct) |
View |
| 2020-09-21 Sale |
2020-09-22 09:48 am |
uniQure N.V. | QURE | Gut Robert Chief Medical Officer |
4,352 | $39.12 | $170,250 | 41,523 (Direct) |
View |
| 2020-06-23 Sale |
2020-06-24 4:21 pm |
uniQure N.V. | QURE | Gut Robert Chief Medical Officer |
26,875 | $70 | $1,881,250 | 99,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-19 Option Award |
2024-06-21 5:19 pm |
N/A 2034-06-19 |
uniQure N.V. | QURE | Gut Robert Director |
23,920 | $0 | 68,085 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-20 5:20 pm |
N/A 2033-06-13 |
uniQure N.V. | QURE | Gut Robert Director |
25,760 | $0 | 64,729 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:46 pm |
N/A 2032-06-15 |
uniQure N.V. | QURE | Gut Robert Director |
26,890 | $0 | 61,975 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 5:02 pm |
N/A 2032-02-24 |
uniQure N.V. | QURE | Gut Robert Director |
4,179 | $0 | 39,332 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 4:36 pm |
N/A 2031-02-25 |
uniQure N.V. | QURE | Gut Robert Director |
6,489 | $0 | 47,408 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-24 4:21 pm |
N/A N/A |
uniQure N.V. | QURE | Gut Robert Chief Medical Officer |
21,875 | $39.97 | 99,000 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-24 4:21 pm |
N/A N/A |
uniQure N.V. | QURE | Gut Robert Chief Medical Officer |
5,000 | $35.4 | 99,000 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-24 4:21 pm |
N/A 2028-06-14 |
uniQure N.V. | QURE | Gut Robert Chief Medical Officer |
26,875 | $0 | 99,000 (Direct) |
View |